DMARDs, a Guide to Monitoring Requirements

Tests for patients on disease-modifying arthritis drugs.

Remind yourself of the monitoring requirements for disease-modifying antirheumatic drugs with the MIMS DMARDs table

This table summarises the ongoing tests advised for patients taking the DMARDs azathioprine, chloroquine, ciclosporin, hydroxychloroquine, leflunomide, methotrexate, penicillamine, sodium aurothiomalate (gold) or sulfasalazine.     

Tests include:

  • full blood counts
  • liver function tests
  • ophthalmological examination
  • renal function and urinalysis
  • blood pressure
  • serum lipids
  • chest x-ray
  • plasma drug levels

The recommended frequency of testing is also noted in the table.

Brand names link through to the full MIMS entries for more detailed prescribing information on each product.

Go to the MIMS DMARDs table

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients on statins do not reach cholesterol goals, study shows

Half of patients prescribed statins fail to reach their...

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

First oral hypoglycaemic licensed for add-on therapy in type I diabetes

The SGLT2 inhibitor dapagliflozin (Forxiga) can now...

Quick-reference MIMS COPD prescribing resources updated

Quick-reference MIMS COPD prescribing resources updated

Concise MIMS resources on COPD management and antibiotic...